Jim Woody Email

CEO, Director . 180 Life Sciences

,

Location

LinkedIn

Current Roles

Employees:
4
Revenue:
$310k
About
180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor).
180 Life Sciences Address
3000 El Camino Real Bldg. 4
null, null
180 Life Sciences Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.